Member Info for alfista

What knowledge do you claim for future product launches?
By Health complete Blue Cap regulation work quite soon, they have demonstrated themselves to be a very go ahead, expansive company. Set that against your zero evidence claim.

Unrealistic level. It was in 09, it is now.
We've all seen shares hijacked by enthusiastic day traders, it will always happen, it is the way of the market.
Value will come, when larger brands appear using Fruitflow. DSM continue to enhance their marketing information, and much more science has supported further patents and potential health claims,
There will be those who say it will never happen, until it happens. That is also the way of the market. One wonders at their motivation.

Reasonably straightforward way to settle it.
Provide the posts where anyone claimed that the H&B launch was a turning point, instead of a welcome development for Provexis Retail, or accept that you were wrong. My own view at the time was that it may well consume more cash as higher stock levels would be required to support it. The DSM contribution for marketing may have taken that in to account, or the full amount, and possibly more, was passed on the H&B. You and Colb think it will fail, I think H&B are no mugs and will have researched well before deciding to add it to their range. It looks like it would be the financial year after the current one before anyone could make any educated guess. Until then I'm expecting a lot more uneducated guesses.
As far as finance requirements goes, should H&B develop a more predictable demand, further factors such as bank funding or invoice factoring are an option, which would ease pressure of shareholder funding. Mr Ford acknowledged those suggestions, describing them as helpful thoughts. As DSM are very obviously still weighing out funds to support brand launches, I'm unsure what level of revenue will be forthcoming from them. Gixer posted evidence of their continuing promotion of Fruitflow awareness to producers. The milestones referred to in the AA may well be dependant on maturing brands which were supported at launch but which are now net contributors. And that is just my speculation based on what we do know of marketing activity to date

In exactly the same way as every time before when you have predicted Armageddon.
If necessary.

I haven't seen anyone claim that H&B would be a turning point, you are inventing that.
It is a Fruitflow product, direct from Provexis, in a multiple retailer. Evidence has appeared that they are giving it some promotion to their staff, and online. Their whole ethos is about recurring revenues from loyal customers. Should blood pressure regulation and alleviation of the effects of air pollution be added to approved health claims, rather than just the patents stage, then they have further powerful tools to appeal to consumers. Gradual increase in awareness. Same has been done on the continent, but nobody follows the numerous Fruitflow brands launched in Germany and other countries. All would consume short term profits due to market support payments, with the prospect of pay back once mature.

If there is to be a "silver bullet" the likelihood is that it would be in China, once Blue Hat approval is complete.
IMHO

Take a look in H&B, or look on their site, Fruitflow doesn't stand out as being out of the normal cost range.
The market is the market, some will buy because stuff is cheap, others will only buy expensive.
Puk, stop this endless obsession with me ehh, you just make yourself look barmy, those around when Dragon posted on here will know his style and mine were never the same, and we were posting on the same board for quite a while. Mind you, I just noticed, there is an "a" in Dragon, and two in alfista. Must be connected.
#couldntmakeitup

Mine cost £14 per 30 tabs.
Well worth it for the improvement in circulatory health.
Couldn't be that H&B know full well that most of their customers haven't a clue about being able to get a cost saving by buying from fruitflowplus.com. I rather think they know their jobs those guys.

Another new high.
Been a very good week

You seem to have a problem with genuine information.
No rest for me, my opinions are based on published information from the company.

More disinformation.
There has been profit from the Alliance Agreement, and it has been shared on the agreed basis.
It has been shown that early stage brand launches are supported by marketing contributions, and that cash outflow would have been substantial as more new products launched. It may even increase greatly if a very big brand were launching. Payback comes further on, so those who think they know how the Alliance works have been proven plain wrong. Both DSM, by paying money up front to support launches, and Provexis, by waiting longer for profits due to the contributions, have shared the load of commercialising Fruitflow. That business case is evidenced by the support of Fruitflow + Omega3 at ;launch, and then another amount more recently to support the H&B launch.
We were told many years ago that it was complex, but still some persist with the thought that it should be simple.

The Company's Alliance Agreement with DSM Nutritional Products for Fruitflow® includes a financial model which is based upon the division of profits between the two partners on an agreed basis, linked to certain revenue targets, following the deduction of the cost of goods and a fixed level of overhead from sales.

Under the revised terms which have been agreed for the Alliance Agreement, the fixed level of overhead deduction from sales will permanently decrease with effect from 1 January 2015, backdated, thus increasing the profit share payable to the Company.

How the devil could you know what I report or not? Apart from the very few where I post that I reported one, have you got some sort of indicator, or are you in some way connected.

An alternative view that doesn't take in to account all of the stages of progress for Fruitflow is not an alternative view, it is a blinkered rant. Your agenda ignores anything that bodes well for the company.

Perhaps you should filter me again if you don't want to read what I post.

I have no control whatsoever over what Admin removes, please stop this incessant accusation against me, Paranoia has no place on here.

You do rant, as does Colb, there is no other word for the stuck record posting that totally dismisses every item of progress with Fruitflow. You are an agenda poster, and as such, you ridicule yourself by your dogmatism

There is on small A trade shown at the Bid, which remains the same as it has for a week or so, so there is no change to the mid price at all.

Colb, the bitterness is yours. You post all the time at the extreme end of negative, all I do is ask folks to consider if the information is balanced, and useful to them when set against published information from the company.. That's all, up to each to decide.

Ultimately, it is for each to decide whether they think that all of the work of DSM, giving Fruitflow high priority in their presentations at industry event after industry event has been without any result, or not. Then they will adjust accordingly their interest here. Or do they think that the ramblings of a multi ID ranter, or a befuddled ex holder or two, are a better indicator of the reality.

There you go again, your promise of filtering me broken. As if you ever did.
By Health isn't a figment of my imagination, neither are the tests and studies for compliance with China laws.
The company says that revenues in the pipeline are " many multiples" of current revenues, and it is blindingly obvious that a small multiple would totally change sentiment.

Keep banging your gloom drum, it has to be answered highlighting the positive moves, so works well for me.

A new high.
It does seem, at last, that the market has woken up to the value here.
IMHO still a lot of headroom

A view that you have expressed for many years. In fact, in your estimation, Provexis should have been gone years ago. Since then, more patents have been added, more articles in medical journals, more seminars for medical professionals, more Fruitflow products added globally, high profile collaboration with Chinese mega retailer By Health. Establishment and expansion of Provexis branded Fruitflow +Omega3 retail product.

Only so many forecasts of Armageddon are effective. After a while, they just look plain daft.

No buying, no selling, folks have established positions

So where is the "improvement in growth" that the same analyst foresaw earlier?
It isn't there is it.
Overpriced, with huge overheads in the internet age.
No thanks, not for me.

Stronger again, are we going to break that 60p ceiling this time?
Bern, the figures weren't mine.
Where the share price will go is as unpredictable as ever. If you take a measure of risk, the reduction of bank borrowings, which were already within more than comfortable parameters, has surely moved risk down a few more notches. If the Innovation Incubator can replicate this first success, it would become a major addition to the existing group.
The dividends are much appreciated, as a proportion of my early buys they are very substantial. I can't help thinking that the policy of growth combined with debt reduction will reap strong rewards in future, especially if general business confidence returns post Brexit. Of course, that event is by no means assured IMHO